Participant's perceptions of a phase I colon cancer chemoprevention trial

Controlled Clinical Trials

Volumn 17, Issue 6, 1996, Pages 494-508

  Hudmon, Karen Suchanek ^a   Stoltzfus, Cynthia ^a   Chamberlain M , Robert ^a   Lorimor, Ronald J ^b   Steinbach, Gideon ^a   Winn, Rodger J ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

cancer prevention; chemoprevention; clinical trial participation; close out questionnaire; participant perceptions

Indexed keywords

CALCIUM CARBONATE; CITRATE CALCIUM;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL TRIAL; COLON CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHASE 1 CLINICAL TRIAL; POPULATION; QUESTIONNAIRE; ADENOCARCINOMA; ATTITUDE; COLON TUMOR; ECONOMICS; MIDDLE AGED; NONPARAMETRIC TEST; PATIENT SELECTION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ATTITUDE; CALCIUM CARBONATE; CALCIUM CITRATE; CLINICAL TRIALS, PHASE I; COLONIC NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; STATISTICS, NONPARAMETRIC;

EID: 0030347104     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(96)00063-3     Document Type: Article

References (23)

1. 1. Rosenstock IM: Historical origins of the health belief model. Health Educ Monographs. 1974;2:328-335.
2. 2. Turk DC. Nonadherence to chemoprevention regimens: a ton of prevention. In: Aiken LH, Mechanic D, eds. Applications of Social Sciences to Clinical Medicine and Health Policy. New Brunswick, NJ: Rutgers University Press;1990:139-149.
3. 3. Insull W, Russell ML. Adherence management in long-term clinical trials for prevention. J Nutr, Growth Cancer. 1987;4:29-35.
4. 4. Berenson M, Groshen S, Miller H, DeCosse J. Subject-reported compliance in a chemoprevention trial for familial adenomatous polyposis. J Behav Med. 1989;12:233-247.
5. 5. Rimer BK. Participant enrollment, participation, and compliance in chemoprevention trials. In: Newell GR, Hong WK, eds. The Biology and Prevention of Aerodigestive Tract Cancers. New York: Plenum Press;1992:111-117.
6. 6. DeMets DL, Newcomb PA, Carey P. Design issues for a breast cancer chemoprevention trial. Prev Med. 1991;20:101-108.
7. 7. Cassileth BR, Lusk EJ, Miller DS, Hurwitz S. Attitudes toward clinical trials among patients and the public. JAMA. 1982;248:968-970.
8. 8. Kemp N, Skinner E, Toms J. Randomized clinical trials of cancer treatment: a public opinion survey. Clin Oncol. 1984;10:155-161.
9. 9. Mattson ME, Curb JD, McArdle R, AMIS Research Group, BHAT Research Group. Participation in a clinical trial: the patients' point of view. Controlled Clin Trials. 1985:6:156-167.
10. 10. Tangrea JA, Adrianza ME, Helsel WE. Patients' perceptions on participation in a cancer chemoprevention trial. Cancer Epidemiol Biomarkers Prev. 1992;1:325-330.
11. 11. Nasco EM, Leonard AD. Assessment of participant satisfaction in a clinical trial by an exit questionnaire. Controlled Clin Trials. 1994;15:43S-44S (abstract).
12. 12. Sutherland HJ, Carlin K, Harper W, Martin LJ, Greenberg CV, Till JE, Boyd NF. A study of diet and breast cancer prevention in Canada: why healthy women participate in controlled trials. Cancer Causes Control. 1993;4:521-528.
13. 13. Henzlova MJ, Blackburn GH, Bradley EJ, Rogers WJ. Patient perception of a long-term clinical trial: Experience using a close-out questionnaire in the studies of left ventricular dysfunction (SOLVD) trial. Controlled Clin Trials. 1994;15:284-293.
14. 14. Kusek J, Lee J, Charleston J, Faulkner M, Levell B, Milligan S, Norris K. Reasons for joining and barriers to participation in the African-American Study of Kidney Disease and Hypertension (AASK) pilot study. Controlled Clin Trials. 1995;16:42S (abstract).
15. 15. Schron EB, Pressel S. Clinical trial participant satisfaction: survey of 4281 participants in the Systolic Hypertension in the Elderly Program. Controlled Clin Trials. 1995;16: 41S-42S (abstract).
16. 16. Steinbach G, Stoltzfus C, Kahn F, Tomayo M, Wargovich M, Levin B, Winn R. Colon cancer chemoprevention study of calcium: Toxicity analysis. Proc Am Assoc Cancer Res. 1994;35:625 (abstract).
17. 17. Carmines EG, Zeller RA. Reliability and Validity. Newbury Park, CA:Sage;.1979.
18. 18. DeVellis RF. Scale Development: Theory and Applications. Newbury Park, CA:Sage;1991.
19. 19. Nunnally JC, Bernstein IH. Psychometric Theory. New York: McGraw-Hill;1994.
20. 20. Gorsuch RL. Factor Analysis. Hillsdale, NJ: Lawrence Erlbaum Associates;1983.
21. 21. Kim JO, Mueller CW. Factor Analysis: Statistical Methods and Practical Issues. Newbury Park, CA:Sage;1978.
22. 22. SPSS Inc., SPSS for Windows™. Advanced Statistics, Release 6.1, Chicago, 1994.
23. 23. Hudmon KS, Chamberlain RM: A comparison of participants and eligible nonparticipants in a head and neck cancer chemoprevention trial. Head and Neck 1994;16: 522 (abstract).